“Repurposing” Disulfiram in the Treatment of Lyme Disease and Babesiosis: Retrospective Review of First 3 Years’ Experience in One Medical Practice

A total of 71 patients with Lyme disease were identified for analysis in whom treatment with disulfiram was initiated between 15 March 2017 and 15 March 2020. Four patients were lost to follow-up, leaving 67 evaluable patients. Our retrospective review found patients to fall into a “high-dose” group...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jiachen, Gong, Zhaodi, Montesano, Dawn, Glazer, Erica, Liegner, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761882/
https://www.ncbi.nlm.nih.gov/pubmed/33291557
http://dx.doi.org/10.3390/antibiotics9120868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761882/
https://www.ncbi.nlm.nih.gov/pubmed/33291557
http://dx.doi.org/10.3390/antibiotics9120868

Ejemplares similares